2025
SJR Q1
JCR Q1 · 3,9
36 eşleşen makale
SCIE
Dergi ayrıntısı
American Journal of Physiology - Heart and Circulatory Physiology
- Yayıncı
- American Physiological Society
- Ülke
- United States · Northern America
- Tür
- journal
- ISSN
-
0363613515221539
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 1,383
- Quartile Q1
- H-Index 235
- Atıf/yayın 3,27
- Doküman (3y) 675
- Atıf (3y) 2.522
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 3,9
- 5Y JIF 4,5
- JCI 1,12
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Cardiology and Cardiovascular Medicine Q1
- Physiology Q1
- Physiology (medical) Q1
Alanlar
- Biochemistry, Genetics and Molecular Biology
- Medicine
WoS kategorileri
- Cardiac & Cardiovascular System | Physiology | Peripheral Vascular Diseases
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 1,383 | 3,9 | 4,5 | 1,12 | Q1 | 235 |
| 2024 | Q1 | Q1 | 1,464 | 4,1 | 4,3 | 1,26 | Q1 | 231 |
| 2023 | Q1 | Q1 | 1,452 | 4,1 | 4,5 | 1,26 | Q1 | 231 |
| 2022 | Q1 | Q1 | 1,283 | 4,8 | 5 | 1,21 | Q1 | 231 |
| 2021 | Q1 | Q1 | 1,473 | 5,1 | 5,3 | 1,16 | Q1 | 231 |
| 2020 | Q1 | Q1 | 1,524 | 4,7 | 4,5 | 1,1 | Q1 | 231 |
| 2019 | Q1 | Q1 | 1,453 | 3,9 | 3,7 | 1,13 | Q1 | 231 |
| 2018 | — | Q1 | — | 4 | 3,9 | 1,11 | Q1 | — |
| 2017 | Q1 | Q1 | 1,61 | 3,6 | 3,7 | 1 | Q1 | 231 |
| 2016 | Q1 | Q2 | 1,669 | 3,3 | 3,6 | — | — | 231 |
| 2015 | Q1 | Q2 | 1,883 | 3,3 | 3,6 | — | — | 231 |
| 2014 | Q1 | Q1 | 1,986 | 3,8 | 3,9 | — | — | 231 |
| 2013 | Q1 | Q1 | 2,069 | 4 | 4 | — | — | 231 |
| 2012 | Q1 | Q1 | 1,848 | 3,6 | 3,9 | — | — | 231 |
| 2011 | Q1 | Q1 | 1,823 | 3,7 | 3,9 | — | — | 231 |
| 2010 | Q1 | Q1 | 1,917 | 3,9 | 3,9 | — | — | 231 |
| 2009 | — | Q1 | — | 3,7 | 3,7 | — | — | — |
| 2008 | — | Q1 | — | 3,6 | 3,7 | — | — | — |
| 2007 | — | Q1 | — | 4 | 3,9 | — | — | — |
| 2006 | — | Q1 | — | 3,7 | — | — | — | — |
| 2005 | — | Q1 | — | 3,6 | — | — | — | — |
| 2004 | — | Q1 | — | 3,5 | — | — | — | — |
| 2003 | — | Q1 | — | 3,7 | — | — | — | — |
| 2002 | — | Q1 | — | 3,4 | — | — | — | — |
| 2001 | — | Q1 | — | 3,2 | — | — | — | — |
| 2000 | — | Q1 | — | 3,2 | — | — | — | — |
| 1999 | — | Q1 | — | 2,7 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | Q1 | 66/237 |
| 2025 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 24/100 |
| 2025 | PHYSIOLOGY | SCIE | Q1 | Q1 | 19/89 |
| 2024 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | Q1 | 51/231 |
| 2024 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 21/98 |
| 2024 | PHYSIOLOGY | SCIE | Q1 | Q1 | 13/87 |
| 2023 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | Q1 | 48/222 |
| 2023 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 16/96 |
| 2023 | PHYSIOLOGY | SCIE | Q1 | Q1 | 15/85 |
| 2022 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | Q1 | 45/143 |
| 2022 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q1 | 20/68 |
| 2022 | PHYSIOLOGY | SCIE | Q1 | Q1 | 14/79 |
| 2021 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | Q1 | 49/143 |
| 2021 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q1 | 21/67 |
| 2021 | PHYSIOLOGY | SCIE | Q1 | Q1 | 15/81 |
| 2020 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | Q1 | 47/142 |
| 2020 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q1 | 19/65 |
| 2020 | PHYSIOLOGY | SCIE | Q1 | Q1 | 13/81 |
| 2019 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | Q1 | 45/138 |
| 2019 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q1 | 18/65 |
| 2019 | PHYSIOLOGY | SCIE | Q1 | Q1 | 13/81 |
| 2018 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | Q1 | 40/136 |
| 2018 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 14/65 |
| 2018 | PHYSIOLOGY | SCIE | Q1 | Q1 | 15/81 |
| 2017 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | Q1 | 45/128 |
| 2017 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 15/65 |
| 2017 | PHYSIOLOGY | SCIE | Q1 | Q2 | 16/83 |
| 2016 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | — | 48/126 |
| 2016 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 22/63 |
| 2016 | PHYSIOLOGY | SCIE | Q2 | — | 22/84 |
| 2015 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | — | 39/124 |
| 2015 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 17/63 |
| 2015 | PHYSIOLOGY | SCIE | Q2 | — | 21/83 |
| 2014 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | — | 32/123 |
| 2014 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 14/60 |
| 2014 | PHYSIOLOGY | SCIE | Q1 | — | 16/83 |
| 2013 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | — | 27/125 |
| 2013 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 14/65 |
| 2013 | PHYSIOLOGY | SCIE | Q1 | — | 12/81 |
| 2012 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | — | 32/124 |
| 2012 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 17/68 |
| 2012 | PHYSIOLOGY | SCIE | Q1 | — | 16/80 |
| 2011 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | — | 29/117 |
| 2011 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 14/68 |
| 2011 | PHYSIOLOGY | SCIE | Q1 | — | 16/79 |
| 2010 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | — | 25/114 |
| 2010 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 14/68 |
| 2010 | PHYSIOLOGY | SCIE | Q1 | — | 14/78 |
| 2009 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | — | 17/95 |
| 2009 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 13/61 |
| 2009 | PHYSIOLOGY | SCIE | Q2 | — | 19/75 |
| 2008 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | — | 19/79 |
| 2008 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 15/56 |
| 2008 | PHYSIOLOGY | SCIE | Q1 | — | 17/74 |
| 2007 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | — | 12/75 |
| 2007 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 13/54 |
| 2007 | PHYSIOLOGY | SCIE | Q1 | — | 13/78 |
| 2006 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | — | 10/74 |
| 2006 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 13/52 |
| 2006 | PHYSIOLOGY | SCIE | Q1 | — | 17/78 |
| 2005 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | — | 11/72 |
| 2005 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 12/51 |
| 2005 | PHYSIOLOGY | SCIE | Q2 | — | 20/75 |
| 2004 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | — | 9/71 |
| 2004 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 11/51 |
| 2004 | PHYSIOLOGY | SCIE | Q1 | — | 13/74 |
| 2003 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | — | 8/70 |
| 2003 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 10/52 |
| 2003 | PHYSIOLOGY | SCIE | Q1 | — | 16/74 |
| 2002 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | — | 8/66 |
| 2002 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 11/52 |
| 2002 | PHYSIOLOGY | SCIE | Q1 | — | 14/73 |
| 2001 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | — | 7/65 |
| 2001 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 12/50 |
| 2001 | PHYSIOLOGY | SCIE | Q1 | — | 17/74 |
| 2000 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | — | 7/63 |
| 2000 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 11/45 |
| 2000 | PHYSIOLOGY | SCIE | Q1 | — | 12/76 |
| 1999 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | — | 9/67 |
| 1999 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 14/44 |
| 1999 | PHYSIOLOGY | SCIE | Q1 | — | 17/74 |